Literature DB >> 16049137

Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling.

Resham Bhattacharya1, Ningling Kang-Decker, Deborah A Hughes, Priyabrata Mukherjee, Vijay Shah, Mark A McNiven, Debabrata Mukhopadhyay.   

Abstract

Vascular endothelial growth factor receptor-2 (VEGFR-2, also known as KDR) is a receptor tyrosine kinase (RTK) regulating mitogenic, chemotactic, permeability, and survival signals in vascular endothelial cells (EC) in response to its ligand, vascular permeability factor/VEGF (VPF/VEGF), arguably the most important angiogenic cytokine. However, the compartmentalization of KDR in EC and the mechanisms regulating this process have not been well defined. Here, we demonstrate that KDR is present on the plasma membrane, on endosomes, and in the perinuclear region of EC and colocalizes with early endosomal antigen (EEA1), caveolin-1, and dynamin-2, a signal transducing GTPase involved in receptor endocytosis. Furthermore, we also observed that dynamin-2 coimmunoprecipitates with KDR and is required for EC signaling/survival. Interestingly, EC overexpressing a mutant form of dynamin deficient in GTP binding (K44A) caused a selective inhibition in KDR protein level and endosomal vesicle formation and induced cell cycle arrest by inducing p21. Taken together, our findings suggest that dynamin-2 regulates KDR expression and function and hence plays an important role in VPF/VEGF mediated angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049137     DOI: 10.1096/fj.05-3889fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  36 in total

1.  Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription.

Authors:  Guangqi E; Ying Cao; Santanu Bhattacharya; Shamit Dutta; Enfeng Wang; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.

Authors:  P I Imoukhuede; Aleksander S Popel
Journal:  Exp Cell Res       Date:  2010-12-23       Impact factor: 3.905

3.  Therapeutic strategies for the inherited neuropathies.

Authors:  Michael E Shy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

4.  Myoferlin is critical for endocytosis in endothelial cells.

Authors:  Pascal N Bernatchez; Arpeeta Sharma; Pinar Kodaman; William C Sessa
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-03       Impact factor: 4.249

5.  Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.

Authors:  Suphansa Sawamiphak; Sascha Seidel; Clara L Essmann; George A Wilkinson; Mara E Pitulescu; Till Acker; Amparo Acker-Palmer
Journal:  Nature       Date:  2010-05-05       Impact factor: 49.962

6.  VEGFR2 translocates to the nucleus to regulate its own transcription.

Authors:  Inês Domingues; José Rino; Jeroen A A Demmers; Primal de Lanerolle; Susana Constantino Rosa Santos
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

7.  Constitutive Endocytosis of VEGFR2 Protects the Receptor against Shedding.

Authors:  Dimitris Basagiannis; Savvas Christoforidis
Journal:  J Biol Chem       Date:  2016-06-13       Impact factor: 5.157

8.  Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity.

Authors:  Anjali Verma; Resham Bhattacharya; Indu Remadevi; Keguo Li; Kallal Pramanik; Ganesh V Samant; Mark Horswill; Chang Z Chun; Baofeng Zhao; Enfeng Wang; Robert Qing Miao; Debabrata Mukhopadhyay; Ramani Ramchandran; George A Wilkinson
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

Review 9.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

10.  Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes.

Authors:  Elizabeth J Pawson; Beatriz Duran-Jimenez; Richard Surosky; Heather E Brooke; S Kaye Spratt; David R Tomlinson; Natalie J Gardiner
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.